Robert is the CEO of Niagen Bioscience.
Niagen Bioscience is the global leader in NAD+ science and healthy aging research. Although it's a vital coenzyme found in every cell, NAD+ declines with age and with everyday stress. This depletion contributes to age-related changes in health and vitality.
With 25+ years leading the industry, Niagen Bioscience advances health span through precision science and innovative NAD+ boosting solutions. At the core is Niagen®, patented nicotinamide riboside (NR), the most efficient, well-researched, and legal NAD+ booster available that is backed by 35+ human clinical trials and 400+ peer-reviewed studies.
The company collaborates with top institutions like NIH, Harvard, and Mayo Clinic through its external research program, which has yielded 275+ global agreements and 175+ publications, including studies on Parkinson’s, Alzheimer’s, inflammation, and heart health.
Niagen powers Tru Niagen®, the #1 NAD+ boosting supplement in the U.S., and Niagen Plus™, a groundbreaking pharmaceutical-grade intravenous product. With over 90 patents, rigorous scientific protocols, and state-of-the-art labs, Niagen Bioscience sets the gold standard for healthy aging innovation.